AU2003223923A1 - Peptide nucleic acid conjugates with transporter peptides - Google Patents
Peptide nucleic acid conjugates with transporter peptidesInfo
- Publication number
- AU2003223923A1 AU2003223923A1 AU2003223923A AU2003223923A AU2003223923A1 AU 2003223923 A1 AU2003223923 A1 AU 2003223923A1 AU 2003223923 A AU2003223923 A AU 2003223923A AU 2003223923 A AU2003223923 A AU 2003223923A AU 2003223923 A1 AU2003223923 A1 AU 2003223923A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- peptide nucleic
- acid conjugates
- transporter peptides
- transporter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200200661 | 2002-05-01 | ||
DKPA200200661 | 2002-05-01 | ||
PCT/DK2003/000280 WO2003092736A2 (en) | 2002-05-01 | 2003-05-01 | Peptide nucleic acid conjugates with transporter peptides |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003223923A1 true AU2003223923A1 (en) | 2003-11-17 |
AU2003223923A8 AU2003223923A8 (en) | 2003-11-17 |
Family
ID=29286046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003223923A Abandoned AU2003223923A1 (en) | 2002-05-01 | 2003-05-01 | Peptide nucleic acid conjugates with transporter peptides |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003223923A1 (en) |
WO (1) | WO2003092736A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8003595B2 (en) | 2000-03-01 | 2011-08-23 | Cellectis | Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
JP4633055B2 (en) * | 2003-08-14 | 2011-02-16 | ディアトス (ソシエテ アノニム) | Antibacterial composition for controlling especially gram-negative bacteria comprising peptides and preferably hydrophobic antibacterial agents |
EP1512696A1 (en) * | 2003-08-14 | 2005-03-09 | Diatos | Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
JP2007515186A (en) * | 2003-12-22 | 2007-06-14 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Methods and compositions for identifying RNA binding proteins |
DE102014101663A1 (en) * | 2014-02-11 | 2015-08-13 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Synthetic artificial peptides with antimicrobial activity |
JP2018504381A (en) * | 2014-12-22 | 2018-02-15 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Cell penetrating peptide |
GB2549798A (en) * | 2016-04-29 | 2017-11-01 | Univ Bradford | Peptides and nanoparticle formulations thereof |
CN114605517B (en) * | 2022-05-12 | 2022-09-27 | 广东海洋大学 | Polypeptide LXP-7 with broad-spectrum anticancer effect and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4421079C1 (en) * | 1994-06-16 | 1995-08-17 | Peter Dr Rer Nat Seibel | New chimaeric peptide nucleic acid construct |
AU734827B2 (en) * | 1997-05-21 | 2001-06-21 | Board Of Trustees Of The Leland Stanford Junior University | Composition and method for enhancing transport across biological membranes |
WO1999005302A1 (en) * | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugates of transporter peptides and nucleic acid analogs, and their use |
EP1220902A2 (en) * | 1998-11-11 | 2002-07-10 | Pantheco A/S | Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
WO2002079467A2 (en) * | 2001-03-29 | 2002-10-10 | Københavns Universitet | Antibiotic-free bacterial strain selection with antisense molecules |
-
2003
- 2003-05-01 AU AU2003223923A patent/AU2003223923A1/en not_active Abandoned
- 2003-05-01 WO PCT/DK2003/000280 patent/WO2003092736A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003092736A2 (en) | 2003-11-13 |
AU2003223923A8 (en) | 2003-11-17 |
WO2003092736A3 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172403A0 (en) | D-amino acid peptides | |
AU2003248119A1 (en) | Novel peptide synthase gene | |
AU2003261398A1 (en) | Peptide aggregates | |
AU6629200A (en) | Alpha-helical peptide nucleic acid alpha-pna | |
AU2002313699A1 (en) | Enzymatic nucleic acid peptide conjugates | |
AU2003290563A1 (en) | Leptin-related peptides | |
AU2003201727A1 (en) | Recombinant protein expression | |
AU2003223923A1 (en) | Peptide nucleic acid conjugates with transporter peptides | |
EP1666588A4 (en) | Novel transporter protein | |
AU2003207744A1 (en) | Transport peptides and uses therefor | |
EP1499635B8 (en) | Teneurin c-terminal associated peptides (tcap) and uses thereof | |
AU2003210778A1 (en) | Amino acid transporters | |
AU2003214038A1 (en) | Peptides with anti-hypertensive properties | |
AU2003269153A1 (en) | Rfamide-related peptide precursor proteins and rfamide peptides | |
AU2003271452A1 (en) | Modified glp-1 peptides with increased biological potency | |
GB0202552D0 (en) | Homeologous peptide nucleic acids | |
AU2003295435A1 (en) | Biological carriers for the delivery of proteins or peptides | |
AU2003236096A1 (en) | Peptide chemically modified with polyethylene glycol | |
AU2003220217A1 (en) | Identifying peptide modifications | |
AU2003270055A1 (en) | Neurotransmission-associated proteins | |
AU2003221472A1 (en) | Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids | |
AU2001259746A1 (en) | Proteins interacting with a sucrose transporter | |
AU2003271848A1 (en) | Transporter/channel proteins | |
AU2002316177A1 (en) | Modified peptide nucleic acid | |
AU2003280316A1 (en) | Zymogen-like protein c polypeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |